Bhushan Dharmadhikari, Phd
Research Scholar, National University of Singapore
immunology
STEMCELLTechnologies
British Indian Ocean Territory
Biography
Bhushan obtained his PhD from the National University of Singapore in 2017. He then joined Dr. Herbert Schwarz’s lab as a postdoc to continue his research in cancer immunology and immunotherapy. The Schwarz lab studies the cytokine receptor CD137 (also known as 4-1BB), and their role in myeloid cells, immune tolerance and malignant diseases, including leukemia and lymphoma. The lab’s research projects aim to develop and improve cancer immunotherapy. Bhushan’s research specifically aims to develop novel dendritic cell (DC)-based immunotherapy. Bhushan obtained his PhD from the National University of Singapore in 2017. He then joined Dr. Herbert Schwarz’s lab as a postdoc to continue his research in cancer immunology and immunotherapy. The Schwarz lab studies the cytokine receptor CD137 (also known as 4-1BB), and their role in myeloid cells, immune tolerance and malignant diseases, including leukemia and lymphoma. The lab’s research projects aim to develop and improve cancer immunotherapy. Bhushan’s research specifically aims to develop novel dendritic cell (DC)-based immunotherapy.
Research Interest
Dendritic cell therapy for cancer CD137 (4-1BB) immunotherapy